Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Related Citations for PubMed (Select 23533264)

1.

Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas.

Drilon A, Wang L, Hasanovic A, Suehara Y, Lipson D, Stephens P, Ross J, Miller V, Ginsberg M, Zakowski MF, Kris MG, Ladanyi M, Rizvi N.

Cancer Discov. 2013 Jun;3(6):630-5. doi: 10.1158/2159-8290.CD-13-0035. Epub 2013 Mar 26.

2.

KIF5B/RET fusion gene in surgically-treated adenocarcinoma of the lung.

Yokota K, Sasaki H, Okuda K, Shimizu S, Shitara M, Hikosaka Y, Moriyama S, Yano M, Fujii Y.

Oncol Rep. 2012 Oct;28(4):1187-92. doi: 10.3892/or.2012.1908. Epub 2012 Jul 13.

PMID:
22797671
3.

The new kid on the block: RET in lung cancer.

Gainor JF, Shaw AT.

Cancer Discov. 2013 Jun;3(6):604-6. doi: 10.1158/2159-8290.CD-13-0174.

4.

RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer.

Wang R, Hu H, Pan Y, Li Y, Ye T, Li C, Luo X, Wang L, Li H, Zhang Y, Li F, Lu Y, Lu Q, Xu J, Garfield D, Shen L, Ji H, Pao W, Sun Y, Chen H.

J Clin Oncol. 2012 Dec 10;30(35):4352-9. doi: 10.1200/JCO.2012.44.1477. Epub 2012 Nov 13.

5.

A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing.

Ju YS, Lee WC, Shin JY, Lee S, Bleazard T, Won JK, Kim YT, Kim JI, Kang JH, Seo JS.

Genome Res. 2012 Mar;22(3):436-45. doi: 10.1101/gr.133645.111. Epub 2011 Dec 22.

6.

RET fusion gene: translation to personalized lung cancer therapy.

Kohno T, Tsuta K, Tsuchihara K, Nakaoku T, Yoh K, Goto K.

Cancer Sci. 2013 Nov;104(11):1396-400. doi: 10.1111/cas.12275. Epub 2013 Oct 1. Review.

PMID:
23991695
7.

Identification of CCDC6-RET fusion in the human lung adenocarcinoma cell line, LC-2/ad.

Matsubara D, Kanai Y, Ishikawa S, Ohara S, Yoshimoto T, Sakatani T, Oguni S, Tamura T, Kataoka H, Endo S, Murakami Y, Aburatani H, Fukayama M, Niki T.

J Thorac Oncol. 2012 Dec;7(12):1872-6. doi: 10.1097/JTO.0b013e3182721ed1.

PMID:
23154560
8.

KIF5B-RET fusions in Chinese patients with non-small cell lung cancer.

Cai W, Su C, Li X, Fan L, Zheng L, Fei K, Zhou C.

Cancer. 2013 Apr 15;119(8):1486-94. doi: 10.1002/cncr.27940. Epub 2013 Feb 1.

PMID:
23378251
9.

Diagnostic method for the detection of KIF5B-RET transformation in lung adenocarcinoma.

Go H, Jung YJ, Kang HW, Park IK, Kang CH, Lee JW, Ju YS, Seo JS, Chung DH, Kim YT.

Lung Cancer. 2013 Oct;82(1):44-50. doi: 10.1016/j.lungcan.2013.07.009. Epub 2013 Aug 9.

PMID:
23932363
10.

RET fusion genes in Korean non-small cell lung cancer.

Yoo SS, Jin G, Jung HJ, Hong MJ, Choi JE, Jeon HS, Lee SY, Lim JO, Park JY.

J Korean Med Sci. 2013 Oct;28(10):1555-8. doi: 10.3346/jkms.2013.28.10.1555. Epub 2013 Sep 25.

11.

KIF5B-RET fusions in lung adenocarcinoma.

Kohno T, Ichikawa H, Totoki Y, Yasuda K, Hiramoto M, Nammo T, Sakamoto H, Tsuta K, Furuta K, Shimada Y, Iwakawa R, Ogiwara H, Oike T, Enari M, Schetter AJ, Okayama H, Haugen A, Skaug V, Chiku S, Yamanaka I, Arai Y, Watanabe S, Sekine I, Ogawa S, Harris CC, Tsuda H, Yoshida T, Yokota J, Shibata T.

Nat Med. 2012 Feb 12;18(3):375-7. doi: 10.1038/nm.2644.

PMID:
22327624
12.

RET-rearranged non-small-cell lung carcinoma: a clinicopathological and molecular analysis.

Tsuta K, Kohno T, Yoshida A, Shimada Y, Asamura H, Furuta K, Kushima R.

Br J Cancer. 2014 Mar 18;110(6):1571-8. doi: 10.1038/bjc.2014.36. Epub 2014 Feb 6.

13.

Cabozantinib: a MET, RET, and VEGFR2 tyrosine kinase inhibitor.

Grüllich C.

Recent Results Cancer Res. 2014;201:207-14. doi: 10.1007/978-3-642-54490-3_12. Review.

PMID:
24756794
14.

KIF5B/RET fusion gene analysis in a selected series of cytological specimens of EGFR, KRAS and EML4-ALK wild-type adenocarcinomas of the lung.

Borrelli N, Giannini R, Proietti A, Alì G, Pelliccioni S, Niccoli C, Lucchi M, Melfi F, Mussi A, Basolo F, Fontanini G.

Lung Cancer. 2013 Sep;81(3):377-81. doi: 10.1016/j.lungcan.2013.06.026. Epub 2013 Jul 25.

PMID:
23891510
15.

RET rearrangements in lung adenocarcinoma and radiation.

Dacic S, Luvison A, Evdokimova V, Kelly L, Siegfried JM, Villaruz LC, Socinski MA, Nikiforov YE.

J Thorac Oncol. 2014 Jan;9(1):118-20. doi: 10.1097/JTO.0000000000000015.

PMID:
24346100
16.

Identification of a lung adenocarcinoma cell line with CCDC6-RET fusion gene and the effect of RET inhibitors in vitro and in vivo.

Suzuki M, Makinoshima H, Matsumoto S, Suzuki A, Mimaki S, Matsushima K, Yoh K, Goto K, Suzuki Y, Ishii G, Ochiai A, Tsuta K, Shibata T, Kohno T, Esumi H, Tsuchihara K.

Cancer Sci. 2013 Jul;104(7):896-903. doi: 10.1111/cas.12175. Epub 2013 May 12.

PMID:
23578175
17.

RET, ROS1 and ALK fusions in lung cancer.

Takeuchi K, Soda M, Togashi Y, Suzuki R, Sakata S, Hatano S, Asaka R, Hamanaka W, Ninomiya H, Uehara H, Lim Choi Y, Satoh Y, Okumura S, Nakagawa K, Mano H, Ishikawa Y.

Nat Med. 2012 Feb 12;18(3):378-81. doi: 10.1038/nm.2658.

PMID:
22327623
18.

Cabozantinib in progressive medullary thyroid cancer.

Elisei R, Schlumberger MJ, Müller SP, Schöffski P, Brose MS, Shah MH, Licitra L, Jarzab B, Medvedev V, Kreissl MC, Niederle B, Cohen EE, Wirth LJ, Ali H, Hessel C, Yaron Y, Ball D, Nelkin B, Sherman SI.

J Clin Oncol. 2013 Oct 10;31(29):3639-46. doi: 10.1200/JCO.2012.48.4659. Epub 2013 Sep 3. Erratum in: J Clin Oncol. 2014 Jun 10;32(17):1864.

19.

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies.

Lipson D, Capelletti M, Yelensky R, Otto G, Parker A, Jarosz M, Curran JA, Balasubramanian S, Bloom T, Brennan KW, Donahue A, Downing SR, Frampton GM, Garcia L, Juhn F, Mitchell KC, White E, White J, Zwirko Z, Peretz T, Nechushtan H, Soussan-Gutman L, Kim J, Sasaki H, Kim HR, Park SI, Ercan D, Sheehan CE, Ross JS, Cronin MT, Jänne PA, Stephens PJ.

Nat Med. 2012 Feb 12;18(3):382-4. doi: 10.1038/nm.2673.

20.

Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.

Kurzrock R, Sherman SI, Ball DW, Forastiere AA, Cohen RB, Mehra R, Pfister DG, Cohen EE, Janisch L, Nauling F, Hong DS, Ng CS, Ye L, Gagel RF, Frye J, Müller T, Ratain MJ, Salgia R.

J Clin Oncol. 2011 Jul 1;29(19):2660-6. doi: 10.1200/JCO.2010.32.4145. Epub 2011 May 23.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk